Access cutting-edge neuroblastoma treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access neuroblastoma specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroblastoma treatment provided free
The purpose of this study is to evaluate the investigational drug, tipifarnib (a pill taken by mouth), in combination with the Food and Drug Administration (FDA) approved drug, naxitimab, administered intravenously (IV; a liquid that continuously goes into your body through a tube that has been placed during a surgery into one of your veins). Naxitamab is FDA approved for pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone
Sponsor: Giselle Sholler
Check if you qualify for this neuroblastoma clinical trial in Portland, OR
If you're searching for neuroblastoma treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.